Neurizon Therapeutics Limited

A$0.06As of Sun 8 Nov 2026, 12:00 UTC
ASX:NUZHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR 0.62%
Div yield —
ROE (137.94%)
Biotechnology
Beta (5Y) 1.16
PE TTM —
TSR TTM (43.40%)
Mkt cap A$49.61M
ROIC (67.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0737
15.19%
8.35%
Hold 2|4|1|9|0
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
11.40%
6.45%
12.97%
13.49%
Revenue$M
6.156
6.410
6.657
6.515
5.56%
11.54%
10.73%
4.26%
Peers (US$34.07M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.853
(1.693)
(1.387)
EBIT/Intx
2.274
1.092
0.795
Own earn%
57.96
49.09
28.39
Sh yield%
21.77
17.09
20.00
Owners
Insiders/Inst%
11.49
78.03
Short interest%
3.16
SBC / revenue%
2.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
22–27
$1 testx
—
Incr. ROIC%
13